Moleculin Biotech, Inc.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 5300 MEMORIAL DRIVE, HOUSTON, TX, 77007
Mailing Address 5300 MEMORIAL DRIVE, HOUSTON, TX, 77007
Phone 713-300-5160
Fiscal Year End 1231
EIN 474671997
Financial Overview
FY2024
$26.07M
Stockholders' Equity
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | February 5, 2026 | View on SEC |
| 8-K Current report of material events | January 20, 2026 | View on SEC |
| 8-K Current report of material events | January 13, 2026 | View on SEC |
| 8-K Current report of material events | January 12, 2026 | View on SEC |
| 8-K Current report of material events | January 7, 2026 | View on SEC |
| DEF 14A Definitive proxy statement | January 2, 2026 | View on SEC |
| S-3 Shelf registration for future offerings | December 23, 2025 | View on SEC |
| 424B5 Prospectus supplement | December 23, 2025 | View on SEC |
| 8-K Current report of material events | December 22, 2025 | View on SEC |
| 8-K Current report of material events | December 17, 2025 | View on SEC |
Material Events
8-K Financial Distress January 7, 2026
High Impact
- Moleculin Biotech successfully regained compliance with Nasdaq's minimum stockholders' equity requirement.
- The company has avoided delisting from the Nasdaq stock exchange.
8-K Financial Distress December 22, 2025
High Impact
- Moleculin Biotech raised $7.9 million through warrant exercises and direct stock sales.
- These financial moves were made to address a potential Nasdaq delisting due to not meeting financial requirements.
8-K Other December 16, 2025
High Impact
- Moleculin Biotech, Inc. successfully regained compliance with Nasdaq's minimum bid price requirement.
- The company's stock closed at or above $1.00 for 10 consecutive business days, from December 1st to December 12th, 2025.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.